Oramed Pharmaceuticals (ORMP) FCF Margin (QoQ) (2016 - 2023)
Oramed Pharmaceuticals (ORMP) FCF Margin (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.40 Mn | 197.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 46,929.00 |
| Mar 31, 2023 | 6,282.00 |
| Dec 31, 2022 | -57,955.00 |
| Sep 30, 2022 | 91,628.00 |
| Jun 30, 2022 | 11,457.00 |
| Nov 30, 2019 | 3,507.00 |
| Aug 31, 2019 | 5,707.00 |
| May 31, 2019 | -25,421.00 |
| Feb 28, 2019 | 33,121.00 |
| Nov 30, 2018 | 13,955.00 |
| Aug 31, 2018 | -13,695.00 |
| May 31, 2018 | -4,120.00 |
| Feb 28, 2018 | -12,902.00 |
| Nov 30, 2017 | -11,477.00 |
| Aug 31, 2017 | 5,062.00 |
| May 31, 2017 | 9,639.00 |
| Feb 28, 2017 | -72,430.00 |
| Nov 30, 2016 | -168,162.00 |
| Aug 31, 2016 | 329,652.00 |
| May 31, 2016 | -322,853.00 |